Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

BACKGROUND: Checkpoint inhibitors (CPIs) are thought to be effective against cutaneous melanoma in part because of the large burden of somatic mutations (neoantigens) generated from exposure to ultraviolet radiation. However, rare melanoma subtypes arising from acral skin, mucosal surfaces, and the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Immunother Cancer
Egile Nagusiak: Klemen, Nicholas D., Wang, Melinda, Rubinstein, Jill C., Olino, Kelly, Clune, James, Ariyan, Stephan, Cha, Charles, Weiss, Sarah A., Kluger, Harriet M., Sznol, Mario
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103823/
https://ncbi.nlm.nih.gov/pubmed/32209601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000341
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak